[Antituberculous chemotherapy: a constraining adverse effect of pyrazinamide].
Mignot
P
P
Dumas
R
R
Lavarenne
J
J
Molina
C
C
D000328:Adult; D004359:Drug Therapy, Combination; D006261:Headache / Q000139:chemically induced*; D006801:Humans; D007592:Joint Diseases / Q000139:chemically induced*; D008297:Male; D010292:Paresthesia / Q000139:chemically induced*; D011718:Pyrazinamide / Q000009:adverse effects*; D014396:Tuberculosis, Pleural / Q000188:drug therapy; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy
D011718:Pyrazinamide
Chimiothérapie antituberculeuse: un effet secondaire contraignant du pyrazinamide.